NYSE:CFN - CareFusion Stock Price, Price Target & More

Notice: This company has been marked as potentially delisted and may not be actively trading.
$59.94 0.00 (0.00 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$59.94
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market Capitalization$12.24 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About CareFusion (NYSE:CFN)

CareFusion logoCareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company's primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive CFN News and Ratings via Email

Sign-up to receive the latest news and ratings for CFN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:CFN
CUSIP14170T10
Phone+1-800-6848880

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins16.18%
Return on Equity12.80%
Return on Assets7.62%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

CareFusion (NYSE:CFN) Frequently Asked Questions

What is CareFusion's stock symbol?

CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."

How were CareFusion's earnings last quarter?

CareFusion Co. (NYSE:CFN) issued its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.79 by $0.20. The healthcare company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The company's quarterly revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.54 earnings per share. View CareFusion's Earnings History.

Has CareFusion been receiving favorable news coverage?

Media stories about CFN stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CareFusion earned a coverage optimism score of 0.20 on Accern's scale. They also gave news headlines about the healthcare company an impact score of 46.33 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

What is CareFusion's stock price today?

One share of CFN stock can currently be purchased for approximately $59.94.

How big of a company is CareFusion?

CareFusion has a market capitalization of $12.24 billion.

How can I contact CareFusion?

CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.


MarketBeat Community Rating for CareFusion (CFN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  154 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe CFN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CFN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CareFusion (NYSE:CFN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/23/2016 forward)

Earnings

CareFusion (NYSE:CFN) Earnings History and Estimates Chart

Earnings by Quarter for CareFusion (NYSE:CFN)

CareFusion (NYSE CFN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2015Q215$0.79$0.99$1.0116 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$0.49$0.50$920.50 million$922.00 millionViewN/AView Earnings Details
8/7/2014Q414$0.72$0.79$1.04 billion$1.1220 billionViewListenView Earnings Details
5/5/2014Q314$0.62$0.60$986.67 million$968.00 millionViewListenView Earnings Details
2/3/2014Q214$0.54$0.54$911.13 million$922.00 millionViewListenView Earnings Details
11/7/2013Q1 2014$0.40$0.44$817.82 million$830.00 millionViewN/AView Earnings Details
8/8/2013Q4 2013$0.56$0.55$918.25 million$903.00 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.53$0.59$909.16 million$901.00 millionViewListenView Earnings Details
2/8/2013Q1 2013$0.55$0.43ViewN/AView Earnings Details
8/9/2012$0.50$0.51ViewN/AView Earnings Details
5/3/2012$0.45$0.49ViewN/AView Earnings Details
2/2/2012$0.43$0.44ViewN/AView Earnings Details
11/7/2011$0.33$0.33ViewN/AView Earnings Details
8/8/2011$0.50$0.52ViewN/AView Earnings Details
5/5/2011$0.40$0.42ViewN/AView Earnings Details
2/3/2011$0.37$0.44ViewN/AView Earnings Details
11/2/2010Q1 2011$0.30$0.30ViewN/AView Earnings Details
8/10/2010Q4 2010$0.37$0.38ViewN/AView Earnings Details
5/6/2010Q3 2010$0.33$0.26ViewN/AView Earnings Details
2/9/2010Q2 2010$0.38$0.39ViewN/AView Earnings Details
11/5/2009Q1 2010$0.26$0.39ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

CareFusion (NYSE:CFN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

CareFusion (NYSE CFN) Insider Trading and Institutional Ownership History

Insider Trading History for CareFusion (NYSE:CFN)

CareFusion (NYSE CFN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2015Jonathan WygantCAOSell1,700$59.79$101,643.00View SEC Filing  
2/6/2015Philip L FrancisDirectorSell40,980$59.89$2,454,292.20View SEC Filing  
12/15/2014Thomas J LeonardInsiderSell25,000$58.87$1,471,750.00View SEC Filing  
12/4/2014Donald AbbeyEVPSell1,000$59.35$59,350.00View SEC Filing  
11/12/2014J Michael LoshDirectorSell12,630$57.32$723,951.60View SEC Filing  
10/6/2014James F HinrichsCFOSell20,000$56.91$1,138,200.00View SEC Filing  
10/6/2014Thomas J LeonardInsiderSell8,400$57.16$480,144.00View SEC Filing  
10/1/2014James F HinrichsCFOSell20,000$45.07$901,400.00View SEC Filing  
9/19/2014Thomas J LeonardInsiderSell16,600$47.01$780,366.00View SEC Filing  
9/15/2014Thomas J LeonardInsiderSell25,000$46.17$1,154,250.00View SEC Filing  
7/7/2014Thomas J LeonardInsiderSell1,250$45.47$56,837.50View SEC Filing  
7/1/2014Thomas J LeonardInsiderSell19,721$45.00$887,445.00View SEC Filing  
6/6/2014James F HinrichsCFOSell21,506$44.07$947,769.42View SEC Filing  
6/2/2014Thomas J LeonardInsiderSell1,250$42.81$53,512.50View SEC Filing  
5/29/2014Fortune Gordon LaEVPSell2,158$42.61$91,952.38View SEC Filing  
5/20/2014Kieran GallahueCEOSell100,000$42.98$4,298,000.00305,122View SEC Filing  
5/19/2014Fortune Gordon LaEVPSell38,738$42.70$1,654,112.6020,894View SEC Filing  
5/19/2014Thomas LeonardInsiderSell30,000$42.89$1,286,700.0034,553View SEC Filing  
5/5/2014Thomas LeonardInsiderSell1,250$39.06$48,825.0034,553View SEC Filing  
4/7/2014Thomas LeonardInsiderSell1,250$40.05$50,062.5035,803View SEC Filing  
4/4/2014Donald AbbeyEVPSell10,076$41.79$421,076.0428,143View SEC Filing  
3/3/2014Thomas LeonardInsiderSell1,250$40.26$50,325.0037,053View SEC Filing  
2/5/2014Philip FrancisDirectorBuy6,500$38.61$250,965.004,515View SEC Filing  
2/5/2014Thomas LeonardInsiderSell21,496$38.24$822,007.0438,303View SEC Filing  
1/9/2014Kieran GallahueCEOSell25,000$41.05$1,026,250.00122,873View SEC Filing  
1/6/2014Thomas LeonardInsiderSell1,250$39.48$49,350.0059,799View SEC Filing  
12/2/2013James HinrichsCFOSell28,078$40.13$1,126,770.1427,024View SEC Filing  
12/2/2013Kieran GallahueCEOSell25,000$40.09$1,002,250.00147,873View SEC Filing  
12/2/2013Thomas LeonardInsiderSell1,250$39.99$49,987.5061,049View SEC Filing  
11/4/2013Thomas J LeonardInsiderSell1,250$39.06$48,825.00View SEC Filing  
10/1/2013Thomas J LeonardInsiderSell1,250$36.99$46,237.50View SEC Filing  
9/9/2013Fortune Gordon LaEVPSell33,960$36.55$1,241,238.00View SEC Filing  
9/3/2013Thomas LeonardInsiderSell1,250$35.70$44,625.0064,799View SEC Filing  
8/26/2013J Michael LoshDirectorSell53,311$35.67$1,901,603.3732,858View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

CareFusion (NYSE CFN) News Headlines

Source:
DateHeadline
Comparing OraSure Technologies (OSUR) and CareFusion (CFN)Comparing OraSure Technologies (OSUR) and CareFusion (CFN)
www.americanbankingnews.com - February 25 at 5:19 PM
CareFusion (CFN) versus Neurometrix (NURO) Head-To-Head ComparisonCareFusion (CFN) versus Neurometrix (NURO) Head-To-Head Comparison
www.americanbankingnews.com - February 12 at 1:24 PM
NuVasive (NUVA) vs. CareFusion (CFN) Head-To-Head AnalysisNuVasive (NUVA) vs. CareFusion (CFN) Head-To-Head Analysis
www.americanbankingnews.com - February 9 at 5:10 AM
Contrasting CareFusion (CFN) & West Pharmaceutical Services (WST)Contrasting CareFusion (CFN) & West Pharmaceutical Services (WST)
www.americanbankingnews.com - February 5 at 5:14 PM
Cardiovascular Systems (CSII) & CareFusion (CFN) Head-To-Head ComparisonCardiovascular Systems (CSII) & CareFusion (CFN) Head-To-Head Comparison
www.americanbankingnews.com - January 28 at 9:14 PM
CareFusion (CFN) versus Its Rivals Head to Head AnalysisCareFusion (CFN) versus Its Rivals Head to Head Analysis
www.americanbankingnews.com - January 27 at 11:26 AM
Financial Contrast: CareFusion (CFN) vs. Its PeersFinancial Contrast: CareFusion (CFN) vs. Its Peers
www.americanbankingnews.com - January 24 at 3:30 PM
Head to Head Survey: CareFusion (CFN) and Its CompetitorsHead to Head Survey: CareFusion (CFN) and Its Competitors
www.americanbankingnews.com - January 22 at 1:20 AM
Head to Head Contrast: CareFusion (CFN) vs. Its CompetitorsHead to Head Contrast: CareFusion (CFN) vs. Its Competitors
www.americanbankingnews.com - January 20 at 11:30 PM
Contrasting ICU Medical (ICUI) & CareFusion (CFN)Contrasting ICU Medical (ICUI) & CareFusion (CFN)
www.americanbankingnews.com - January 20 at 7:50 PM
CareFusion (CFN) and Its Competitors Head-To-Head AnalysisCareFusion (CFN) and Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - January 19 at 7:37 AM
CareFusion (CFN) and Its Competitors Financial AnalysisCareFusion (CFN) and Its Competitors Financial Analysis
www.americanbankingnews.com - January 16 at 3:10 AM
Head to Head Analysis: CareFusion (CFN) vs. Its PeersHead to Head Analysis: CareFusion (CFN) vs. Its Peers
www.americanbankingnews.com - January 13 at 9:26 AM
Reviewing CareFusion (CFN) and Its CompetitorsReviewing CareFusion (CFN) and Its Competitors
www.americanbankingnews.com - January 7 at 7:32 PM
CareFusion (CFN) & Its Peers Financial ComparisonCareFusion (CFN) & Its Peers Financial Comparison
www.americanbankingnews.com - January 3 at 5:36 AM
CareFusion (CFN) and The Competition Financial ContrastCareFusion (CFN) and The Competition Financial Contrast
www.americanbankingnews.com - December 29 at 9:30 PM
Invacare (IVC) vs. CareFusion (CFN) Critical ContrastInvacare (IVC) vs. CareFusion (CFN) Critical Contrast
www.americanbankingnews.com - December 4 at 12:02 PM
Head-To-Head Analysis: CareFusion (CFN) versus Align Technology (ALGN)Head-To-Head Analysis: CareFusion (CFN) versus Align Technology (ALGN)
www.americanbankingnews.com - October 21 at 12:26 AM
Reviewing CareFusion (CFN) & SeaSpine Holdings Corporation (SPNE)Reviewing CareFusion (CFN) & SeaSpine Holdings Corporation (SPNE)
www.americanbankingnews.com - September 1 at 6:24 PM
Head to Head Survey: Steris Plc (STE) and CareFusion (CFN)Head to Head Survey: Steris Plc (STE) and CareFusion (CFN)
www.americanbankingnews.com - August 24 at 12:20 AM
Medical Tech Firm Becton Dickinson Agrees to Buy C.R. Bard For $24 BillionMedical Tech Firm Becton Dickinson Agrees to Buy C.R. Bard For $24 Billion
fortune.com - April 24 at 9:40 AM
[$$] Becton Dickinson Could Pump Out Steady Gains[$$] Becton Dickinson Could Pump Out Steady Gains
www.barrons.com - October 23 at 8:52 AM
Becton, Dickinson: What I Will Be Looking Out For In Todays ResultsBecton, Dickinson: What I Will Be Looking Out For In Today's Results
seekingalpha.com - February 3 at 11:55 AM
[$$] Becton Dickinson Tops Expectations[$$] Becton Dickinson Tops Expectations
www.wsj.com - November 4 at 1:43 PM
CAREFUSION CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or DispCAREFUSION CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp
biz.yahoo.com - March 17 at 9:39 AM

SEC Filings

CareFusion (NYSE:CFN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

CareFusion (NYSE:CFN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

CareFusion (NYSE CFN) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.